Cargando…

Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study

Early in the course of immunotherapy there is frequently a transient enlargement of tumor masses (pseudo-progression) due to tumor infiltration by TILs. Current clinical imaging modalities are not able to distinguished pseudo-progression from true tumor progression. Thus, patients often remain on tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markovic, Svetomir N., Galli, Filippo, Suman, Vera J., Nevala, Wendy K., Paulsen, Andrew M., Hung, Joseph C., Gansen, Denise N., Erickson, Lori A., Marchetti, Paolo, Wiseman, Gregory A., Signore, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084386/ https://www.ncbi.nlm.nih.gov/pubmed/30100988 http://dx.doi.org/10.18632/oncotarget.25666

Ejemplares similares

Endogenous Heat‐Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma
por: Domingo‐Musibay, Evidio, et al.
Publicado: (2017)

Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2015)

The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
por: Mansfield, Aaron S., et al.
Publicado: (2013)

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma
por: Holtan, Shernan G., et al.
Publicado: (2011)

Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
por: Galli, Filippo, et al.
Publicado: (2020)

A prospective evaluation of the role of Vascular Endothelial Growth Factor (VEGF) and the immune system in stage III/IV melanoma
por: Agostino, Nicole Marie, et al.
Publicado: (2015)

Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma
por: Grotz, Travis E, et al.
Publicado: (2015)

Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab
por: Butterfield, John T., et al.
Publicado: (2017)

Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation
por: Maus, Rachel L. G., et al.
Publicado: (2017)

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20(+) B-cell lymphoma
por: Nevala, Wendy K., et al.
Publicado: (2017)

Reinvigorating tumour-infiltrating lymphocytes from checkpoint inhibitor resistant melanomas
por: Silva, Inês Pires da, et al.
Publicado: (2018)

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)
por: Vera Aguilera, Jesus, et al.
Publicado: (2018)

Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma
por: Maus, Rachel L.G., et al.
Publicado: (2019)

Cancer immune control dynamics: a clinical data driven model of systemic immunity in patients with metastatic melanoma
por: Frisch, Harold P., et al.
Publicado: (2021)

Fetal Sex-Based Differences in Maternal Hormones, Angiogenic Factors, and Immune Mediators During Pregnancy and the Postpartum Period
por: Enninga, Elizabeth Ann L, et al.
Publicado: (2015)

Therapy for metastatic melanoma: the past, present, and future
por: Finn, Laura, et al.
Publicado: (2012)

Resolving the Heterogeneous Tumor-Centric Cellular Neighborhood through Multiplexed, Spatial Paracrine Interactions in the Setting of Immune Checkpoint Blockade
por: Maus, Rachel L.G., et al.
Publicado: (2022)

Understanding heterogeneous tumor microenvironment in metastatic melanoma
por: Yan, Yiyi, et al.
Publicado: (2019)

Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors
por: Hirai, Ikuko, et al.
Publicado: (2021)

Growth Modeling of the Maternal Cytokine Milieu throughout Normal Pregnancy: Macrophage-Derived Chemokine Decreases as Inflammation/Counterregulation Increases
por: Holtan, Shernan G., et al.
Publicado: (2015)

Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients
por: Manohar, Sandhya, et al.
Publicado: (2019)

Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to Immune Checkpoint Blockade
por: Sahni, Sahil, et al.
Publicado: (2023)

Results of NCCTG N0275 (Alliance) – a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma
por: Rule, William G., et al.
Publicado: (2016)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

OR32-02 Immune Checkpoint Inhibitor-Induced Hypophysitis Is Associated with Improved Overall Survival in Cancer Patients
por: Kotwal, Anupam, et al.
Publicado: (2020)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
por: Yan, Yiyi, et al.
Publicado: (2018)

Dominant effects of Δ40p53 on p53 function and melanoma cell fate
por: Takahashi, Rie, et al.
Publicado: (2013)

250 A Living Library for Uveal Melanoma
por: Dalvin, Lauren A., et al.
Publicado: (2023)

Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases
por: Chatziioannou, Eftychia, et al.
Publicado: (2023)

Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
por: Kodumudi, Krithika N., et al.
Publicado: (2016)

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma
por: Youland, Ryan S., et al.
Publicado: (2017)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
por: Maibach, Fabienne, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
por: Betof Warner, Allison, et al.
Publicado: (2023)

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era
por: Youland, Ryan S., et al.
Publicado: (2017)

Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
por: Vermeulen, Jeroen F., et al.
Publicado: (2017)

Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
por: Hasan Ali, Omar, et al.
Publicado: (2020)

Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2017)

Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600(E/K) mutated malignant melanomas
por: Klein, Sebastian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_acm76v7d6r6knv1n8or0db7kjt